AsOf

Recorded or changed on this day 2026-11-08

501–550 of 46,473 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 53,358,622,000 United States dollar
Abbott Laboratories total assets: 53,358,622,000 United States dollar, claim clm_E59D8BD6F57C · ended · superseded by clm_CCF6757E8FC3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 960,000,000 United States dollar
Abbott Laboratories quarterly net income: 960,000,000 United States dollar, claim clm_E5DF870B61C4 · ended · superseded by clm_3BBCD8D2245C · 1 source (1 primary) · conf 0.95
unverified: One source so far: shown on the record, not asserted, until a second source or a primary one confirms it.
Abbott Laboratories · website · https://abbott.com
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 9,040,850,000 United States dollar
Abbott Laboratories quarterly revenue: 9,040,850,000 United States dollar, claim clm_E6DA945AC1D9 · ended · superseded by clm_2BC0D1181F4B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 729,000,000 United States dollar
Abbott Laboratories quarterly operating income: 729,000,000 United States dollar, claim clm_E789F7FC62E7 · ended · superseded by clm_0E1A644D6289 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 4,048,000,000 United States dollar
Abbott Laboratories cash and equivalents: 4,048,000,000 United States dollar, claim clm_E79667D75AE6 · ended · superseded by clm_278DC080FBE9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,557,795,578 shares
Abbott Laboratories shares outstanding: 1,557,795,578 shares, claim clm_E7CEC88C5131 · ended · superseded by clm_E1EBF63517AF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 5,751,948,000 United States dollar
Abbott Laboratories operating income: 5,751,948,000 United States dollar, claim clm_E857AF3C6172 · ended · superseded by clm_DB14BAE02A47 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 59,628,176,000 United States dollar
Abbott Laboratories total assets: 59,628,176,000 United States dollar, claim clm_E8CD9FA5F500 · ended · superseded by clm_E061E4681AB9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 32,784,000,000 United States dollar
Abbott Laboratories total equity: 32,784,000,000 United States dollar, claim clm_E91F357595A5 · ended · superseded by clm_9B3045B3D04C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 32,032,000,000 United States dollar
Abbott Laboratories total equity: 32,032,000,000 United States dollar, claim clm_E93715A27F70 · ended · superseded by clm_9D7A48D859AE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 11,142,000,000 United States dollar
Abbott Laboratories quarterly revenue: 11,142,000,000 United States dollar, claim clm_E9EFA461ED0C · ended · superseded by clm_4D4D4E6FC869 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 563,000,000 United States dollar
Abbott Laboratories quarterly net income: 563,000,000 United States dollar, claim clm_EA18E0C4D59D · ended · superseded by clm_7FCB849C8A66 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 521,192,000 United States dollar
Abbott Laboratories cash and equivalents: 521,192,000 United States dollar, claim clm_EA473BD097AA · ended · superseded by clm_06133819F221 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 733,000,000 United States dollar
Abbott Laboratories quarterly net income: 733,000,000 United States dollar, claim clm_EA6CC4097E8D · ended · superseded by clm_EA18E0C4D59D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,570,677,029 shares
Abbott Laboratories shares outstanding: 1,570,677,029 shares, claim clm_EC2D60D2CF76 · ended · superseded by clm_DB844C28FB13 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 17,778,540,000 United States dollar
Abbott Laboratories total equity: 17,778,540,000 United States dollar, claim clm_EC2D6AAD0FF7 · ended · superseded by clm_34A4F9C5D46A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,396,517,000 United States dollar
Abbott Laboratories quarterly operating income: 1,396,517,000 United States dollar, claim clm_EE3783948414 · ended · superseded by clm_BF0249D28592 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 11,164,000,000 United States dollar
Abbott Laboratories quarterly revenue: 11,164,000,000 United States dollar, claim clm_EF0BC6C103EE · ended · superseded by clm_88335AA7BB99 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 29,527,552,000 United States dollar
Abbott Laboratories revenue: 29,527,552,000 United States dollar, claim clm_F17A9DA7A446 · ended · superseded by clm_BF21BA903CA4 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · research and development · 2,742,000,000 United States dollar
Abbott Laboratories research and development: 2,742,000,000 United States dollar, claim clm_F186D437CBF8 · ended · superseded by clm_2B9EF111FA51 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 21,403,932,000 United States dollar
Abbott Laboratories total equity: 21,403,932,000 United States dollar, claim clm_F1A1F85FFC33 · ended · superseded by clm_D23ECD8FDCAC · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 50,000,000 United States dollar
Abbott Laboratories quarterly research and development: 50,000,000 United States dollar, claim clm_F26A204C1C56 · ended · superseded by clm_D0387CB879C0 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 672,000,000 United States dollar
Abbott Laboratories quarterly research and development: 672,000,000 United States dollar, claim clm_F2D32AEB2B4A · ended · superseded by clm_24C066E1F3E1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,543,070,300 shares
Abbott Laboratories shares outstanding: 1,543,070,300 shares, claim clm_F3B60AD32165 · ended · superseded by clm_398EA7EAB5B8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 767,000,000 United States dollar
Abbott Laboratories quarterly research and development: 767,000,000 United States dollar, claim clm_F408F42211E9 · ended · superseded by clm_A04DCE763037 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 7,761,336,000 United States dollar
Abbott Laboratories quarterly revenue: 7,761,336,000 United States dollar, claim clm_F40C461D1F9A · ended · superseded by clm_882692ECC7C2 · 1 source (1 primary) · conf 0.95
unverified: One source so far: shown on the record, not asserted, until a second source or a primary one confirms it.
Abbott Laboratories · headquarters · North Chicago
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 6,951,000,000 United States dollar
Abbott Laboratories cash and equivalents: 6,951,000,000 United States dollar, claim clm_F462DB1216CF · ended · superseded by clm_4D88D9F7190C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 6,803,000,000 United States dollar
Abbott Laboratories cash and equivalents: 6,803,000,000 United States dollar, claim clm_F4A9C9EE7593 · ended · superseded by clm_427132599EAB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly research and development · 672,000,000 United States dollar
Abbott Laboratories quarterly research and development: 672,000,000 United States dollar, claim clm_F557BBEDA577 · ended · superseded by clm_67490CE86700 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 2,882,454,000 United States dollar
Abbott Laboratories cash and equivalents: 2,882,454,000 United States dollar, claim clm_F56B3CD1FDAB · ended · superseded by clm_11779D774E56 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 20,776,000,000 United States dollar
Abbott Laboratories total equity: 20,776,000,000 United States dollar, claim clm_F5A188432375 · ended · superseded by clm_8210275EABD7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 34,422,000,000 United States dollar
Abbott Laboratories total equity: 34,422,000,000 United States dollar, claim clm_F790E66651DD · ended · superseded by clm_962B09128298 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · operating income · 4,578,545,000 United States dollar
Abbott Laboratories operating income: 4,578,545,000 United States dollar, claim clm_F857B97BF253 · ended · superseded by clm_9A47D1F92763 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,740,459,014 shares
Abbott Laboratories shares outstanding: 1,740,459,014 shares, claim clm_F9BD3860CF3E · ended · superseded by clm_0F8EC0C78816 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly net income · 2,100,000,000 United States dollar
Abbott Laboratories quarterly net income: 2,100,000,000 United States dollar, claim clm_F9C12EA9C926 · ended · superseded by clm_9A8A8D8C7B07 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 22,336,064,000 United States dollar
Abbott Laboratories total equity: 22,336,064,000 United States dollar, claim clm_FA0A4E638F4A · ended · superseded by clm_CFE8748CEC34 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 2,578,000,000 United States dollar
Abbott Laboratories cash and equivalents: 2,578,000,000 United States dollar, claim clm_FA8D28D995F1 · ended · superseded by clm_6E48EACB3253 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · revenue · 35,166,721,000 United States dollar
Abbott Laboratories revenue: 35,166,721,000 United States dollar, claim clm_FBAB25A659DE · ended · superseded by clm_80F33B0D967B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · shares outstanding · 1,768,286,969 shares
Abbott Laboratories shares outstanding: 1,768,286,969 shares, claim clm_FC36D396E40F · ended · superseded by clm_324EB82497B2 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 6,812,820,000 United States dollar
Abbott Laboratories cash and equivalents: 6,812,820,000 United States dollar, claim clm_FC9A90EC2807 · ended · superseded by clm_E1E87B6DD7DE · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly revenue · 5,551,000,000 United States dollar
Abbott Laboratories quarterly revenue: 5,551,000,000 United States dollar, claim clm_FD8317313DF1 · ended · superseded by clm_82A6A707FD7C · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · quarterly operating income · 1,386,000,000 United States dollar
Abbott Laboratories quarterly operating income: 1,386,000,000 United States dollar, claim clm_FDE13F28F4C1 · ended · superseded by clm_D714148AE67A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total equity · 22,888,000,000 United States dollar
Abbott Laboratories total equity: 22,888,000,000 United States dollar, claim clm_FE809BBE39B1 · ended · superseded by clm_D31BB3649B18 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 10,802,163,000 United States dollar
Abbott Laboratories cash and equivalents: 10,802,163,000 United States dollar, claim clm_FEB167E490AD · ended · superseded by clm_C0BA9C433C47 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · cash and equivalents · 3,226,000,000 United States dollar
Abbott Laboratories cash and equivalents: 3,226,000,000 United States dollar, claim clm_FF3EC9A8A46B · ended · superseded by clm_E79667D75AE6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Abbott Laboratories · total assets · 70,887,000,000 United States dollar
Abbott Laboratories total assets: 70,887,000,000 United States dollar, claim clm_FFC8F38C32CB · ended · superseded by clm_CDC7CB62542B · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · total equity · -5,935,000,000 United States dollar
AbbVie total equity: -5,935,000,000 United States dollar, claim clm_00E837EDC859 · ended · superseded by clm_FA883B408C6E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
AbbVie · quarterly net income · 1,631,000,000 United States dollar
AbbVie quarterly net income: 1,631,000,000 United States dollar, claim clm_013E1D0CE6A0 · ended · superseded by clm_A64BC7BE871E · 1 source (1 primary) · conf 0.95

What the statuses mean